TERADATA CORP /DE/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TERADATA CORP /DE/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,322	2,156	2,164	1,899	1,836	1,917	1,795	1,833	1,750	1,663
Cost of revenue	1,133	1,132	1,138	944	817	731	714	718	692	676
Gross profit	1,189	1,024	1,026	955	1,019	1,186	1,081	1,115	1,058	987
Research and development	212	305	317	327	334	309	313	294	284	280
Selling, general and administrative	662	651	666	618	669	646	650	635	565	502
Operating income	235	68	43	10	16	231	118	186	209	205
Interest expense	12	15	22	26	27	26	24	30	29	26
Interest income	6	11	14	12	4	6	15
Other non-operating income	-11	-6	-16	-23	-40	-39	-51	-69	-45	-27
Pre-tax income	221	58	27	-13	-24	192	67	117	164	178
Income tax	96	125	-3	7	-153	45	34	55	50	48
Net income	125	-67	30	-20	129	147	33	62	114	130
EBITDA	363	206	173	160	188	380	252	302	309	295
EPS, basic	0.96	-0.53	0.25	-0.18	1.18	1.35	0.32	0.62	1.18	1.38
EPS, diluted	0.95	-0.53	0.25	-0.18	1.16	1.30	0.31	0.61	1.16	1.35
Shares, basic (weighted)	130	126	119	114	109	109	103	99.8	96.4	94.4
Shares, diluted (weighted)	132	126	121	114	112	113	106	102	98.2	96.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	974	1,089	715	494	529	592	569	486	420	493
Receivables	548	554	588	398	331	336	364	286	234	251
Inventory	34	30	28	31	29	26	8	13	18	13
Other current assets	65	77	97	91	155	152	87	84	77	80
Total current assets	1,621	1,750	1,428	1,014	1,044	1,106	1,028	869	749	837
Property, plant and equipment	138	162	295	350	339	288	244	239	185	198
Lease right-of-use assets			0	51	38	26	13	9	8	7
Goodwill	390	399	395	396	401	396	390	398	394	399
Intangible assets	11	23	16	91	98	111	92	68	46	42
Other non-current assets	17	44	49	68	51	40	42	69	96	87
Total assets	2,413	2,556	2,360	2,057	2,193	2,169	2,022	1,873	1,704	1,779
Accounts payable	103	74	141	66	50	67	94	100	106	96
Accrued liabilities	139	173	224	157	170	148	137	130	111	120
Deferred revenue	369	414	490	472	499	552	589	570	512	533
Short-term debt	30	60	19	25	44	88	0	19	25	25
Total current liabilities	729	1,063	1,009	886	952	1,033	1,007	996	930	914
Long-term debt	538	478	478	454	411	324	498	480	455	431
Lease liabilities			0	38	28	18	10	6	5	4
Other non-current liabilities	32	149	127	138	136	109	79	61	28	18
Total liabilities	1,442	1,888	1,865	1,795	1,793	1,709	1,764	1,738	1,571	1,549
Total debt	568	538	497	479	455	412	498	499	480	456
Paid-in capital	1,220	1,320	1,418	1,545	1,656	1,808	1,941	2,074	2,192	2,305
Retained earnings	-161	-579	-823	-1,143	-1,114	-1,211	-1,565	-1,811	-1,913	-1,923
Other comprehensive income	-89	-74	-101	-141	-143	-138	-119	-129	-147	-153
Shareholders' equity	971	668	495	262	400	460	258	135	133	230
Total equity	971	668	495	262	400	460	258	135	133	230
Total liabilities and equity	2,413	2,556	2,360	2,057	2,193	2,169	2,022	1,873	1,704	1,779
Shares outstanding		122	117	111	109	107	101	97.9	95.1	92.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	125	-67	30	-20	129	147	33	62	114	130
Depreciation and amortization	128	138	130	150	172	149	134	116	100	90
Stock-based compensation	62	68	65	83	101	112	126	126	119	112
Deferred income tax	-3	-34	-18	-3	-118	14	-26	-11	-11	31
Change in receivables	40	-6	-34	190	67	-5	-28	78	52	-17
Change in inventory	14	3	2	-3	2	3	18	-5	-5	5
Change in payables	11	12	108	-153	0	17	35	7	-1	-48
Cash from operations	446	324	364	148	267	463	419	375	303	305
Capital expenditures	-53	-78	-153	-54	-44	-28	-14	-19	-24	-19
Sales and maturities of investments	2	0	0
Cash from investing	-35	-108	-163	-59	-51	-31	-18	-49	-32	-21
Debt issued					0	0	500	0	0
Debt repaid	-30	-30	-40	-19	-25	-44	-413	0	-19	-25
Stock issued	18	19	21	32	0	31	3
Share buybacks	-82	-351	-300	-300	-100	-244	-387	-308	-215	-140
Cash from financing	-262	-109	-554	-308	-186	-356	-381	-383	-306	-233
Exchange rate effect	-14	8	-20	-1	7	-14	-44	-28	-30	22
Net change in cash	135	115	-373	-220	37	62	-24	-85	-65	73
Free cash flow	393	246	211	94	223	435	405	356	279	286
Interest paid	12	14	23	26	27	26	23	30	29	26
Income taxes paid	105	25	33	33	39	44	-18	65	75	71

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $28.94 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	60.8%	Gross profit / revenue.
Operating margin	7.5%	Operating income / revenue.
EBITDA margin	13.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	34.9%	Pre-tax income / revenue.
Net margin	27.1%	Net income / revenue.
FCF margin	43.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	45.0%	Cash from operations / revenue.
Effective tax rate	22.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	77.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	27.6%	Net income / average total assets.
Return on invested capital (ROIC)	55.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	17.1%	Research and development expense / revenue.
SG&A / revenue	36.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	4.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.5%	Capital expenditures / revenue.
D&A / revenue	5.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-6.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-0.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-1.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	20.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	66.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-4.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	9.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	14.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	57.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	0.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	16.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	63.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	3.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	0.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-10.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	2.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-10.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	5.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	72.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-3.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-10.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.91x	Current assets / current liabilities.
Quick ratio	0.79x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.49x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	64.2%	Total liabilities / total assets.
Net debt	-$414.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-1.86x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.08x	Operating income / interest expense.
Working capital	-$72.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	26.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$157.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.02x	Revenue / average total assets.
Fixed asset turnover	8.85x	Revenue / average property, plant and equipment.
Inventory turnover	133x	Cost of revenue / average inventory.
Days inventory	3 days	365 x average inventory / cost of revenue.
Receivables turnover	6.61x	Revenue / average receivables.
Days sales outstanding	55 days	365 x average receivables / revenue.
Days payables	30 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	28 days	Days inventory + days sales outstanding - days payables.
FCF conversion	160.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.76	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$17.58	Revenue / diluted weighted shares.
FCF per share	$7.65	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.91	Cash from operations / diluted weighted shares.
Book value per share	$6.16	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.63	Tangible book value / shares outstanding.
Cash per share	$4.30	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	19.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.69B	Share price x shares outstanding.
Enterprise value	$2.28B	Market cap + total debt - cash - short-term investments.
P/E	5.88x	Market cap / net income. Only when net income is positive.
P/S	1.59x	Market cap / revenue.
P/B	4.54x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	17.1x	Market cap / tangible book value, when positive.
P/FCF	3.66x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.54x	Market cap / cash from operations, when positive.
EV/Sales	1.35x	Enterprise value / revenue.
EV/EBIT	17.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	10.3x	Enterprise value / EBITDA, when both are positive.
EV/FCF	3.09x	Enterprise value / free cash flow, when both are positive.
FCF yield	27.3%	Free cash flow / market cap.
Earnings yield	17.0%	Net income / market cap (the inverse of P/E).
Shareholder yield	5.3%	(Dividends paid + share buybacks) / market cap.
PEG	0.09x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was TERADATA CORP /DE/'s revenue in fiscal 2025?

TERADATA CORP /DE/ reported revenue of $1.66B for fiscal 2025, 5% lower than the year before.

Was TERADATA CORP /DE/ profitable in fiscal 2025?

Yes. Net income was $130.0M, a net margin of 7.8%.

How much free cash flow did TERADATA CORP /DE/ generate in fiscal 2025?

Cash from operations of $305.0M minus capital expenditures of $19.0M left free cash flow of $286.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TERADATA CORP /DE/